Figure 2.
Residual disease status by intraperitoneal disease dissemination patterns, among 741 patients with high-grade serous ovarian cancer. Percentages based on the number of patients in each pattern group with information on residual disease (pelvic, N=67; lower abdominal, N=110 of 111; upper abdominal, N=440 of 445, miliary, N=113 of 118).